Health

NEW YORK TIMES                                                                  Oct 15, 2014
By DONALD G. McNEIL Jr.

A dummy depicting an Ebola patient was part of a C.D.C. training session for health care workers Wednesday in Anniston, Ala. Credit Erik S. Lesser/European Pressphoto Agency

LIBERIA: ANALYSIS OF EBOLA'S IMPACT ON THE ECONOMY

WASHINGTON POST                           OCT. 15, 2014

By Ylan Q. Mui
MONROVIA                                      

"  the (Ebola) tragedy encompasses not only those who lost their lives and their families, but also the dreams of a country that was on the cusp on an economic resurgence. With critical public works projects in limbo and businesses struggling, the virus is threatening Liberia’s chance to escape generations of poverty and join Africa’s rising prosperity.

“Liberia was moving,” said Estrada Bernard, chairman of the International Bank in Liberia and the Liberian president’s brother-in-law. “'The whole thing hinges upon how well we can get this virus under control.'”

People do business at the Waterside local market in the center of Monrovia, Liberia, over the summer. Just as their economies had begun to recover from the man-made horror of coups and civil war, the West African nations of Guinea, Liberia and Sierra Leone have been knocked back down by the Ebola virus. (AP Photo/Abbas Dulleh, File)

FIERCE BOIOTECH RESEARCH                       Oct. 14, 2014
By Emily Mullin

Before the current Ebola outbreak, the virus had only appeared in Africa in fits and starts since its discovery in 1976, receding back into the jungle almost as quickly as it arrived. This relative rarity and the swiftness with which the disease kills its victims has, up until now, made Ebola an unattractive--not to mention daunting--prospect for drug developers. As a result, no approved drugs or vaccines against Ebola exist.

...the current situation in West Africa... has prompted the World Health Organization to call on international government agencies and the pharmaceutical industry to work together to speed up the development of promising therapies for experimental use for those most at risk of contracting the disease, which causes severe hemorrhagic fever.

Now, a handful of players are racing to get a treatment or vaccine to patients as quickly as possible, even though these drugs remain largely untested in humans.... 

Here is a list of organizations that are in the global spotlight right now with their investigational Ebola program

See full story and list

NBC NEWS                                                            OCT. 14, 2014

Facebook founder Mark Zuckerberg and his wife announced Tuesday they are donating $25 million to the U.S. Centers for Disease Control foundation to fight the Ebola crisis that has killed more than 4,440 people in west Africa.

"We need to get Ebola under control in the near term so that it doesn't spread further and become a long term global health crisis that we end up fighting for decades at large scale, like HIV or polio," Zuckerberg, who is worth $32 billion, said in a Facebook post. "We believe our grant is the quickest way to empower the CDC and the experts in this field to prevent this outcome."

The health agency has hundreds of staffers working on Ebola and has sent more than 100 experts to the virus zone — Liberia, Guinea, Sierra Leone and Nigeria. The CDC foundation collects funds for supplies, such as personal protective equipment, ready-to-eat meals, generators, vehicles and motorcycles, and thermal scanners to detect fever.

See full story